These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 19568226

  • 1. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF.
    Am J Gastroenterol; 2009 Aug; 104(8):2089-96. PubMed ID: 19568226
    [Abstract] [Full Text] [Related]

  • 2. Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride?
    Velayos FS, Sandborn WJ.
    Am J Gastroenterol; 2009 Aug; 104(8):2097-9. PubMed ID: 19661939
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF.
    Rev Gastroenterol Disord; 2003 Aug; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [Abstract] [Full Text] [Related]

  • 4. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T, Watanabe T.
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [Abstract] [Full Text] [Related]

  • 5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 6. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 7. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [Abstract] [Full Text] [Related]

  • 8. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
    Peyrin-Biroulet L, Oussalah A, Roblin X, Sparrow MP.
    Aliment Pharmacol Ther; 2011 Mar; 33(6):707-13. PubMed ID: 21251032
    [Abstract] [Full Text] [Related]

  • 9. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC.
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
    Ardizzone S, Bollani S, Manzionna G, Colombo E, Maconi G, Imbesi V, Bianchi Porro G.
    Ann Ital Chir; 2003 Dec; 74(6):621-5. PubMed ID: 15206802
    [Abstract] [Full Text] [Related]

  • 12. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI, Present DH.
    J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W, Stange EF, International AZT-2 Study Group.
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract] [Full Text] [Related]

  • 14. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN, Ben Abdallah H, Houissa F, Bouali MR, Khediri MF.
    Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
    [Abstract] [Full Text] [Related]

  • 15. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S.
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract] [Full Text] [Related]

  • 16. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F.
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract] [Full Text] [Related]

  • 17. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G, Herfarth H.
    Dtsch Med Wochenschr; 2002 May 31; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract] [Full Text] [Related]

  • 18. Immunosuppressants and Crohn's disease.
    Goldstein F.
    Gastroenterology; 1972 May 31; 62(5):1101-2. PubMed ID: 5029074
    [No Abstract] [Full Text] [Related]

  • 19. [Immunosuppressive treatment of Crohn's disease].
    Kasper H, Auer I.
    Dtsch Z Verdau Stoffwechselkr; 1976 May 31; 36(3-4):143-5. PubMed ID: 1021382
    [No Abstract] [Full Text] [Related]

  • 20. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP, Hanauer SB.
    Am J Gastroenterol; 2000 May 31; 95(5):1139-46. PubMed ID: 10811318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.